Company Profiles

driven by the PitchBook Platform

Akashi Therapeutics

Description

Developer of treatments for Duchenne muscular dystrophy and other rare pediatric diseases. The company is developing medications for transforming Duchenne from a fatal, aggressive muscle-wasting disease to a chronic, manageable condition.

2010

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$1.5M

Latest Deal Amount

$1.5M

Total Amount Raised

Description

Developer of treatments for Duchenne muscular dystrophy and other rare pediatric diseases. The company is developing medications for transforming Duchenne from a fatal, aggressive muscle-wasting disease to a chronic, manageable condition.

Website:

www.akashirx.com

Formerly Known As

Dart Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

245 First Street 18th Floor Cambridge, MA 02142United States +1 (617) 431-7250
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Akashi Therapeutics's full profile, request a free trial.

Akashi Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Akashi Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Charley's FundOther000 0000000 0000
MDA Venture PhilanthropyCorporate Venture CapitalMinority000 0000000 0000
Nash Avery FoundationOther000 0000000 0000
Charley's Fund Other
MDA Venture Philanthropy Corporate Venture Capital
Nash Avery Foundation Other

Akashi Therapeutics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Lance ThibaultDirector, Finance
Marc BlausteinChief Executive Officer & Board Member
Benjamin SecklerCo-Founder
Diana Escolar MDChief Medical Officer
Ernest Bush Ph.DChief Scientific Officer
Lance Thibault Director, Finance
Marc Blaustein Chief Executive Officer & Board Member
Benjamin Seckler Co-Founder
Diana Escolar MD Chief Medical Officer
Ernest Bush Ph.D Chief Scientific Officer

Akashi Therapeutics Board Members (3)

NameRepresentingRoleSinceContact
Info
Marc BlausteinAkashi TherapeuticsChief Executive Officer & Board Member000 0000
Tom WickaSelfCo-Founder, Board Member & Interim Chief Executive Officer000 0000
Tracy SecklerCharley's FundDirector000 0000
Marc Blaustein Chief Executive Officer & Board Member Akashi Therapeutics
Tom Wicka Co-Founder, Board Member & Interim Chief Executive Officer Self
Tracy Seckler Director Charley's Fund
Request full access to PitchBook